Vimarsana
Biggest News Aggregation in the World

Page 3 - Aktx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aktx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aktx Today - Breaking & Trending Today

Akari Therapeutics (NASDAQ:AKTX) Earns Sell Rating from Analysts at StockNews.com - Vimarsana News

Akari Therapeutics (NASDAQ:AKTX) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research report sent to investors on Monday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance Akari Therapeutics stock opened at $3.60 on Monday. Akari Therapeutics has a twelve month low of $2.81 and a […]

Source: wkrb13.com
Akari Therapeutics (NASDAQ:AKTX) Earns Sell Rating from Analysts at StockNews.com - Vimarsana News

Akari Therapeutics (NASDAQ:AKTX) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report released on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Up 1.2 % NASDAQ AKTX opened at $3.45 on Friday. Akari Therapeutics has a 12 month low of $2.81 and a 12 […]

Source: wkrb13.com
Akari Therapeutics (NASDAQ:AKTX) Now Covered by Analysts at StockNews.com - Vimarsana News

Akari Therapeutics (NASDAQ:AKTX) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report issued on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance Shares of NASDAQ AKTX opened at $3.45 on Friday. The business has a 50 day simple moving average of $3.67 and a […]

Akari Therapeutics (NASDAQ:AKTX) Earns Sell Rating from Analysts at StockNews.com - Vimarsana News

Akari Therapeutics (NASDAQ:AKTX) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research note released on Friday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance Shares of Akari Therapeutics stock opened at $3.88 on Friday. The company’s fifty day moving average price is $3.96 and […]

Akari Therapeutics (NASDAQ:AKTX) Coverage Initiated at StockNews.com - Vimarsana News

Akari Therapeutics (NASDAQ:AKTX) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report released on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance Shares of NASDAQ:AKTX opened at $3.61 on Friday. The firm has a fifty day moving average of $3.84 and a 200 […]